Aimmune Therapeutics Inc (NASDAQ: AIMT) provided finalized data highlights
Aimmune Therapeutics Inc (NASDAQ: AIMT), just recently reported financial results for the quarter and nine months ended September 30, 2019.
Read moreAimmune Therapeutics Inc (NASDAQ: AIMT), just recently reported financial results for the quarter and nine months ended September 30, 2019.
Read more